An opinion piece in Forbes contested the position taken by the New York Times on vaping regulations.
Yesterday, the New York Times published an editorial titled “Big Tobacco Attacks Sensible FDA Vaping Rules.” Two points for debate surface immediately.
First is the question of just how sensible those rules really are. Second is the insinuation that tobacco companies should play no role in developing nicotine products that are far less hazardous than cigarettes.
By conflating products with their makers, the editorialists miss a crucial point about public health: that smokers are best served when safer alternatives to cigarettes are developed and available without needless delay.
Read the rest at www.forbes.com
